Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Y01-5-0013-11 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| New York MDRU | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.
The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Methylphenidate | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Dopamine receptor availability |
Not provided
Not provided
Inclusion Criteria:
Healthy normals
Exclusion Criteria:
History of head trauma or loss of consciousness. Significant medical history. History of seizures.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John Rotrosen, M.D. | New York MDRU | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York MDRU | New York | New York | 10010 | United States |
Not provided
| ID | Term |
|---|---|
| D019970 | Cocaine-Related Disorders |
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D008774 | Methylphenidate |
| ID | Term |
|---|---|
| D010648 | Phenylacetates |
| D000146 | Acids, Carbocyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D010880 |
| Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |